Dr Elizabeth Roundhill
- Position: Research Fellow
- Email: E.A.Roundhill@leeds.ac.uk
- Phone: +44(0)113 206 4922
Profile
I received my BSc in cell biology from University of Durham in 2005 and completed my PhD in the Children’s Cancer Research Group at the University of Leeds in 2009, investigating multi-drug resistance in Ewing sarcoma. After completing a Post-Doctoral position in Leeds, I joined the Children’s Cancer Institute, Sydney, Australia, as a Post-Doctoral Research Officer involved in the preclinical testing of novel therapeutics. I returned to the Children’s Cancer Research Group in Leeds in 2015 as an Early Career Research Fellow to develop more representative models of bone sarcoma for use in drug repurposing and targeted screening approaches. My current research is focussed on the identification of novel therapeutic targets and biomarkers to improve outcomes for patients with Ewing sarcoma.
Qualifications
- BSc
- PhD
Professional memberships
- EuroEwing Consortium (EEC) member (2020-present)
- EEC New Ewing Therapeutics Strategy Group (NEWTS) (2023-present)
- EEC Circulating Biomakers Group (2024-present)
- INTER-EWING1 Biological Studies Steering Group (2023-present)
- Fight OsteoSarcoma Through European Research (FOSTER) (2021-present)
- American Association of Cancer Research (2007-present)
- British Association of Cancer Research (2005-present)
- NCRI Sarcoma CSG Trainee (2018-2023)
- NCRI Bone Sarcoma CSG subgroup (2015-2023)
- International Society of Paediatric Cancer (SIOP) (2015-present)
Research groups and institutes
- Leeds Institute of Medical Research at St James's